MCM
CNCE

Matarin Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Matarin Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-316,858
Closed -$5.33M – 315
2018
Q2 		$5.33M Buy
316,858
+31,408
+11% +$529K 0.39% 93
2018
Q1 		$6.54M Buy
285,450
+137,237
+93% +$3.14M 0.49% 76
2017
Q4 		$3.83M Buy
+148,213
New +$3.83M 0.3% 128